Skip to main content
. 2020 Aug 5;5(3):e19.00068. doi: 10.2106/JBJS.OA.19.00068

TABLE I.

Patient Characteristics*

Case No. Age in Years, Sex Location Size (cm3) Pathological Fracture ASB Dimensions of Exposed Articular Cartilage (mm) Preop. KL Grade KL Grade at Latest Follow-up Contralateral KL Grade Postop. Osteoarthritis Bone-Modifying Agents Follow-up Period (mo) Additional Operation
1 29, M DF 45 No 7% 2 × 7 0 0 0 98 Re-curettage
2 30, M DF 36 No 3% 3 × 6 0 3 0 Secondary 111 OWHTO
3 20, F DF 75 Yes 38% 3 × 3 0 1 0 Secondary 102 Hardware removal
4 41, F DF 40 No 10% 5 × 4 1 1 1 112
5 60, F PT 84 No 11% 11 × 6 2 4 2 Secondary Denosumab 112 TKA
6 33, F PT 90 No 27% 2 × 4 1 1 1 117
7 35, F DF 66 No 17% NA 1 2 1 Secondary 128
8 43, M PT 39 No 10% 0 1 1 1 139
9 28, M DF 57 No 17% 5 × 6 0 0 0 66
10 59, F DF 96 No 21% 8 × 9 1 3 1 Secondary Bisphosphonate 69
11 27, M DF 66 No 8% 0 0 0 0 140
12 31, F PT 66 No 42% 5 × 6 0 0 0 141
13 63, F PT 15 No 13% NA 1 2 2 Age-related Bisphosphonate 155
14 58, M DF 80 No 12% NA 1 1 1 165
15 26, F PT 42 No 18% 0 0 0 0 172
16 33, F DF 32 No 10% NA 0 0 0 169
17 61, F DF 60 No 17% NA 1 2 2 Age-related 193
18 28, F DF 54 No 53% 7 ×9 0 0 0 205
19 20, M PT 36 No 19% 9 × 9 0 0 0 Denosumab 104
*

ASB = amount of subchondral bone involvement, preop. = preoperative, postop. = postoperative, DF = distal aspect of the femur, OWHTO = open-wedge high tibial osteotomy, PT = proximal aspect of the tibia, TKA = total knee arthroplasty, and NA = not applicable.